Inventor
GREEN NEAL
US17 patents
⚠️ This page may combine multiple inventors who share the name “GREEN NEAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
9 patentsUS10208052B1Feb 19, 2019
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC36 citations97
US10675274B2Jun 9, 2020
Activating pyruvate kinase R
FORMA THERAPEUTICS INC12 citations94
US10472371B2Nov 12, 2019
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC13 citations92
US11649242B2May 16, 2023
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
FORMA THERAPEUTICS INC5 citations85
US11396513B2Jul 26, 2022
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC6 citations85
US11071725B2Jul 27, 2021
Activating pyruvate kinase R
FORMA THERAPEUTICS INC8 citations84
US11014927B2May 25, 2021
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
FORMA THERAPEUTICS INC6 citations84
US10836771B2Nov 17, 2020
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC7 citations84
US11001588B2May 11, 2021
Activating pyruvate kinase R and mutants thereof
FORMA THERAPEUTICS INC3 citations73
NOVO NORDISK HEALTHCARE AG
6 patentsUS11980611B2May 14, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG3 citations85
US11844787B2Dec 19, 2023
Activating pyruvate kinase R
NOVO NORDISK HEALTHCARE AG5 citations85
US12122778B2Oct 22, 2024
Activating pyruvate kinase R
NOVO NORDISK HEALTHCARE AG0 citations62
US12071440B2Aug 27, 2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
NOVO NORDISK HEALTHCARE AG0 citations62
US12053458B2Aug 6, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG0 citations62
US12128035B2Oct 29, 2024
Activating pyruvate kinase R
NOVO NORDISK HEALTHCARE AG1 citations57